Studies using genome-wide association (GWA) single nucleotide polymorphism (SNP) level
data have indicated genetic overlap across the five major disorders in the Psychiatric …

Objective: The authors conducted a review of the history and empirical basis of genomewide
association studies (GWAS), the rationale for GWAS of psychiatric disorders, results to date …

Neuropsychiatric disorders, such as autism spectrum disorder (ASD), attention deficit
hyperactivity disorder (ADHD), schizophrenia (SCZ), bipolar disorder (BIP), and major …

Objectives. Genome-wide association studies (GWAS) in complex phenotypes, including
psychiatric disorders, have yielded many replicated findings, yet individual markers account …

Substantial genetic liability is shared across psychiatric disorders but less is known about
risk variants that are specific to a given disorder. We used multi-trait conditional and joint …

Genome-wide association (GWAS) analyses have identified susceptibility loci for many
diseases, but most risk for any complex disorder remains unattributed. There is therefore …

Genome-wide association studies (GWAS) have yielded a plethora of new findings in the
past 3 years. By early 2009, GWAS on 47 samples of subjects with attention-deficit …

Today multinational studies using genome-wide association scan (GWAS) for> 1000, 000
polymorphisms on> 100,000 cases with major psychiatric diseases versus controls …

We conducted a cross-trait meta-analysis of genome-wide association study on
schizophrenia (SCZ)(n= 65,967), bipolar disorder (BD)(n= 41,653), autism spectrum …

Most psychiatric disorders are moderately to highly heritable. The degree to which genetic
variation is unique to individual disorders or shared across disorders is unclear. To examine …